Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Jubilant Life Sciences

    Tag: Jubilant Life Sciences

    You Searched For "Jubilant Life Sciences"
    Jubilant Life Sciences Karnataka plant shut on coronavirus scare

    Jubilant Life Sciences Karnataka plant shut on coronavirus scare

    Medical Dialogues Bureau8 April 2020 2:15 PM IST
    Mysuru: The drug-making plant of pharma major Jubilant Life Sciences at Nanjangud near here has been shut down after it was suspected to have been...
    Jubilant gets USFDA EIR for its Solid Dosage facility at Salisbury, Maryland USA

    Jubilant gets USFDA EIR for its Solid Dosage facility at Salisbury, Maryland USA

    Medical Dialogues Bureau2 April 2020 2:18 PM IST
    Noida: Jubilant Life Sciences Limited, an integrated global Pharmaceutical and Life Sciences Company, has announced that Jubilant Pharma Limited, a...
    Jubilant Life Sciences Q3 profit falls 23.97pc at Rs 203.38 crore

    Jubilant Life Sciences Q3 profit falls 23.97pc at Rs 203.38 crore

    Medical Dialogues Bureau1 Feb 2020 9:45 AM IST
    Drug firm Jubilant Life Sciences on Friday reported a 23.97 per cent fall in consolidated net profit at Rs 203.38 crore for the third quarter ended...
    Penalty levied by SEBI on Jubilant Life Sciences reduced to Rs 5 lakh

    Penalty levied by SEBI on Jubilant Life Sciences reduced to Rs 5 lakh

    Medical Dialogues Bureau8 Nov 2019 9:30 AM IST
    "We have found that the appellant in... Jubilant Life Sciences would be liable for a penalty only on one count i.e. for non-disclosure of the China...
    Jubilant Life Sciences appoints Alok Vaish as CFO, Key Managerial Personnel

    Jubilant Life Sciences appoints Alok Vaish as CFO, Key Managerial Personnel

    Medical Dialogues Bureau30 Oct 2019 9:00 AM IST
    New Delhi: Jubilant Life Sciences has recently announced its board has approved the appointment of Alok Vaish as Chief Financial Officer and Key...
    Jubilant Life appoints Novartis Syed Kazmi as President, CEO of its new biotech startup

    Jubilant Life appoints Novartis Syed Kazmi as President, CEO of its new biotech startup

    Medical Dialogues Bureau11 Sept 2019 9:25 AM IST
    Dr Syed Kazmi joins from Novartis Pharmaceuticals Corporation where he was Vice President, Global Head of Business Development & Licensing for...
    Jubilant Life Sciences net profit slips 7.68 percent to Rs 185 crore for June quarter

    Jubilant Life Sciences net profit slips 7.68 percent to Rs 185 crore for June quarter

    Farhat Nasim29 July 2019 9:00 AM IST
    "We have had a steady performance during the quarter. Pharmaceutical segment revenues have been higher by 12 per cent YoY led by growth in CMO,...
    Jubilant Life Sciences posts net loss of Rs 100.65 crore in Q4

    Jubilant Life Sciences posts net loss of Rs 100.65 crore in Q4

    Garima19 May 2019 9:30 AM IST
    Jubilant Life Sciences said its bottom line in the quarter was hit by a one-time loan settlement with IFC, that resulted in an exceptional item of Rs...
    Cipla appoints Dr Raju Mistry as Global Chief People Officer

    Cipla appoints Dr Raju Mistry as Global Chief People Officer

    Medical Dialogues Bureau23 April 2019 9:15 AM IST
    In her role at Cipla, Raju Mistry will oversee Human Resources, and Administration and Facilities Management. She will be a member of the Management...
    SEBI slaps Rs 50 lakh penalty on Jubilant Life Sciences and 4 others

    SEBI slaps Rs 50 lakh penalty on Jubilant Life Sciences and 4 others

    Ruby Khatun Khatun2 Feb 2018 12:21 PM IST
    New Delhi: SEBI imposed a total fine of Rs 50 lakh on Jubilant Life Sciences, its three promoter entities and a director for violation of norms...

    Popular Stories

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok